Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis

Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
M Dimitrijevic, R R Bartlett

Abstract

A novel immunomodulating drug, leflunomide has been shown recently to be effective and well tolerated in patients suffering from rheumatoid arthritis (RA). The present study evaluated the effect of the drug on cell adhesion in RA. Peripheral blood and synovial fluid mononuclear cells were obtained from a clinical trial, undertaken primarily to evaluate the efficacy and pharmacokinetic profile of multiple-dose pulsing leflunomide therapy in RA patients. PB MNC and corresponding synovial fluid (SF) MNC for in vitro homotypic aggregation (HA) assay were obtained from healthy volunteers and RA patients with active disease not treated with leflunomide in vivo. Expression of activation antigens (CD25, CD54, CD69, CD71, HLA-DR) on peripheral blood mononuclear cells (PB MNC), as well as ex vivo ability of cells to aggregate spontaneously were determined in patients before entering into the clinical trial and at the end of 6 months treatment. HA was measured by aggregation in vitro. Data were compared by Student's t-test. There was a decreased expression of activation antigens and decreased spontaneous MNC clustering after leflunomide therapy. We found in the in vitro study that HA of PB and SF MNC was mainly mediated through beta 2-int...Continue Reading

References

Jan 1, 1991·Annual Review of Immunology·M L Dustin, T A Springer
Sep 1, 1991·Clinical Immunology and Immunopathology·M Patarroyo
Aug 2, 1990·Nature·T A Springer
Sep 1, 1990·Scandinavian Journal of Immunology·T A Springer
Feb 1, 1990·Scandinavian Journal of Immunology·A J PotocnikR A Kroczek
Aug 1, 1989·Scandinavian Journal of Immunology·M Patarroyo, M W Makgoba
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P BurnS J Singer
Oct 1, 1995·Immunology Today·M LubC G Figdor
Jul 1, 1995·Immunology Today·N Hogg, C Berlin
Nov 1, 1994·The Journal of Pathology·G Khan, P J Coates
Jan 1, 1993·Springer Seminars in Immunopathology·R R BartlettR Schleyerbach
Aug 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·T ZielinskiR R Bartlett

❮ Previous
Next ❯

Citations

Feb 7, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·K G Moder
Jul 15, 1999·Clinical and Experimental Immunology·S Stosic-GrujicicR Bartlett
Nov 18, 2004·Annals of the Rheumatic Diseases·J GrisarJ S Smolen
Mar 4, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Malte C Claussen, Thomas Korn
Nov 13, 2007·Biophysical Journal·Sheila G CoutoAntonio J Costa-Filho
Jun 25, 2004·The British Journal of Dermatology·J SchmittC Pfeiffer
Jul 19, 2018·Future Medicinal Chemistry·Lucas Vb HoelzNubia Boechat
Sep 16, 2003·Journal of Leukocyte Biology·Esther Layseca-EspinosaYvonne Rosenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.